China NT Pharma | Sustainability Performance
Develops, manufactures, and markets pharmaceutical products and therapies across multiple treatment areas.
1995
China
11 - 50 employees
Pharmaceuticals
$1M - 10M in revenue
Not profitable
Sustainability Ranking & Industry Benchmark
#11414
Overall#654
in China#267
in PharmaceuticalsSustainability Maturity
Sustainability Intent
Overview
Governance
TargetsESG scores and ExclusionsFinancial Data
Business performanceCapital & innovationAnalyst projections
Revenue
Controversy level
Powered by illuminem
Revenue
EBITDA
Operating margin
Revenue & EBITDA
$37.0MFY2024 revenue
Total Annual
Revenue & EBITDA
($ B)
Annual revenue
EBITDA
3 year change
Margin trends
Margin as % of revenue
Gross margin
Operating margin
Net margin
Powered by illuminem
Free cashflow
Capex
Debt/equity ratio
Return on invested capital
230.0%FY2026
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Analyst revenue estimates & actuals
Analyst consensus vs actuals
($ B)
Actual revenue
Consensus estimates
Estimate only
0.0
20230.0
2024Powered by illuminem
Environmental policy coverage
Carbon reduction policy
Not available
Human rights policy
Not available
Recycling policy
Not available
Workplace health & safety policy
Not available
33%
Independent Directors
3 out of 9 incl. management
Overall score
0
Environment
0
Social
0
Governance
0
Exclusion screening
Adult content
Not available
Alcoholic
Not available
Animal testing
Not available
Firearms
Not available
Tobacco
Not available
Gambling
Not available
Nuclear
Not available
